Copyright Reports & Markets. All rights reserved.

Global Cell therapy Processing Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Cell therapy Processing Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Products
      • 1.4.3 Services
      • 1.4.4 Software
    • 1.5 Market by Application
      • 1.5.1 Global Cell therapy Processing Market Share by Application (2014-2025)
      • 1.5.2 Cardiovascular Disease
      • 1.5.3 Bone Repair
      • 1.5.4 Neurological Disorders
      • 1.5.5 Skeletal Muscle RepairImmune Diseases
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Cell therapy Processing Market Size
    • 2.2 Cell therapy Processing Growth Trends by Regions
      • 2.2.1 Cell therapy Processing Market Size by Regions (2014-2025)
      • 2.2.2 Cell therapy Processing Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Cell therapy Processing Market Size by Manufacturers
      • 3.1.1 Global Cell therapy Processing Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Cell therapy Processing Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Cell therapy Processing Market Concentration Ratio (CR5 and HHI)
    • 3.2 Cell therapy Processing Key Players Head office and Area Served
    • 3.3 Key Players Cell therapy Processing Product/Solution/Service
    • 3.4 Date of Enter into Cell therapy Processing Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Cell therapy Processing Market Size by Type (2014-2019)
    • 4.2 Global Cell therapy Processing Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Cell therapy Processing Market Size (2014-2019)
    • 5.2 Cell therapy Processing Key Players in United States
    • 5.3 United States Cell therapy Processing Market Size by Type
    • 5.4 United States Cell therapy Processing Market Size by Application

    6 Europe

    • 6.1 Europe Cell therapy Processing Market Size (2014-2019)
    • 6.2 Cell therapy Processing Key Players in Europe
    • 6.3 Europe Cell therapy Processing Market Size by Type
    • 6.4 Europe Cell therapy Processing Market Size by Application

    7 China

    • 7.1 China Cell therapy Processing Market Size (2014-2019)
    • 7.2 Cell therapy Processing Key Players in China
    • 7.3 China Cell therapy Processing Market Size by Type
    • 7.4 China Cell therapy Processing Market Size by Application

    8 Japan

    • 8.1 Japan Cell therapy Processing Market Size (2014-2019)
    • 8.2 Cell therapy Processing Key Players in Japan
    • 8.3 Japan Cell therapy Processing Market Size by Type
    • 8.4 Japan Cell therapy Processing Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Cell therapy Processing Market Size (2014-2019)
    • 9.2 Cell therapy Processing Key Players in Southeast Asia
    • 9.3 Southeast Asia Cell therapy Processing Market Size by Type
    • 9.4 Southeast Asia Cell therapy Processing Market Size by Application

    10 India

    • 10.1 India Cell therapy Processing Market Size (2014-2019)
    • 10.2 Cell therapy Processing Key Players in India
    • 10.3 India Cell therapy Processing Market Size by Type
    • 10.4 India Cell therapy Processing Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Cell therapy Processing Market Size (2014-2019)
    • 11.2 Cell therapy Processing Key Players in Central & South America
    • 11.3 Central & South America Cell therapy Processing Market Size by Type
    • 11.4 Central & South America Cell therapy Processing Market Size by Application

    12 International Players Profiles

    • 12.1 Anthrogenesis Corp.
      • 12.1.1 Anthrogenesis Corp. Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Cell therapy Processing Introduction
      • 12.1.4 Anthrogenesis Corp. Revenue in Cell therapy Processing Business (2014-2019)
      • 12.1.5 Anthrogenesis Corp. Recent Development
    • 12.2 BioNTech
      • 12.2.1 BioNTech Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Cell therapy Processing Introduction
      • 12.2.4 BioNTech Revenue in Cell therapy Processing Business (2014-2019)
      • 12.2.5 BioNTech Recent Development
    • 12.3 Cell Ideas
      • 12.3.1 Cell Ideas Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Cell therapy Processing Introduction
      • 12.3.4 Cell Ideas Revenue in Cell therapy Processing Business (2014-2019)
      • 12.3.5 Cell Ideas Recent Development
    • 12.4 Epic Sciences
      • 12.4.1 Epic Sciences Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Cell therapy Processing Introduction
      • 12.4.4 Epic Sciences Revenue in Cell therapy Processing Business (2014-2019)
      • 12.4.5 Epic Sciences Recent Development
    • 12.5 Roche
      • 12.5.1 Roche Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Cell therapy Processing Introduction
      • 12.5.4 Roche Revenue in Cell therapy Processing Business (2014-2019)
      • 12.5.5 Roche Recent Development
    • 12.6 FuGENE
      • 12.6.1 FuGENE Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Cell therapy Processing Introduction
      • 12.6.4 FuGENE Revenue in Cell therapy Processing Business (2014-2019)
      • 12.6.5 FuGENE Recent Development
    • 12.7 IBC Pharmaceuticals Inc.
      • 12.7.1 IBC Pharmaceuticals Inc. Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Cell therapy Processing Introduction
      • 12.7.4 IBC Pharmaceuticals Inc. Revenue in Cell therapy Processing Business (2014-2019)
      • 12.7.5 IBC Pharmaceuticals Inc. Recent Development
    • 12.8 Bluebird Bio Inc.
      • 12.8.1 Bluebird Bio Inc. Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Cell therapy Processing Introduction
      • 12.8.4 Bluebird Bio Inc. Revenue in Cell therapy Processing Business (2014-2019)
      • 12.8.5 Bluebird Bio Inc. Recent Development
    • 12.9 Immodulon-Therapeutics
      • 12.9.1 Immodulon-Therapeutics Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Cell therapy Processing Introduction
      • 12.9.4 Immodulon-Therapeutics Revenue in Cell therapy Processing Business (2014-2019)
      • 12.9.5 Immodulon-Therapeutics Recent Development
    • 12.10 Immunomedics Inc.
      • 12.10.1 Immunomedics Inc. Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Cell therapy Processing Introduction
      • 12.10.4 Immunomedics Inc. Revenue in Cell therapy Processing Business (2014-2019)
      • 12.10.5 Immunomedics Inc. Recent Development
    • 12.11 Juno Therapeutics Inc.
    • 12.12 Medlmmune Inc.
    • 12.13 NeoStem Oncology
    • 12.14 Neurotech USA
    • 12.15 Novartis
    • 12.16 Persimmune Inc.
    • 12.17 Pluristem Therapeutics
    • 12.18 BioMed Valley Discoveries Inc.
    • 12.19 Regeneron Pharmaceuticals Inc.
    • 12.20 UCL Business PLC.

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Cell therapy is the transplantation of human cells to replace or repair damaged tissue or cells. With new technologies and innovative products, many different types of cells can be used as part of a therapy or a treatment for a variety of diseases and conditions.
      In 2018, the global Cell therapy Processing market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Cell therapy Processing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cell therapy Processing development in United States, Europe and China.

      The key players covered in this study
      Anthrogenesis Corp.
      BioNTech
      Cell Ideas
      Epic Sciences
      Roche
      FuGENE
      IBC Pharmaceuticals Inc.
      Bluebird Bio Inc.
      Immodulon-Therapeutics
      Immunomedics Inc.
      Juno Therapeutics Inc.
      Medlmmune Inc.
      NeoStem Oncology
      Neurotech USA
      Novartis
      Persimmune Inc.
      Pluristem Therapeutics
      BioMed Valley Discoveries Inc.
      Regeneron Pharmaceuticals Inc.
      UCL Business PLC.

      Market segment by Type, the product can be split into
      Products
      Services
      Software

      Market segment by Application, split into
      Cardiovascular Disease
      Bone Repair
      Neurological Disorders
      Skeletal Muscle RepairImmune Diseases

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Cell therapy Processing status, future forecast, growth opportunity, key market and key players.
      To present the Cell therapy Processing development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Cell therapy Processing are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now